Catamaran Bio

📍 Boston, United States🗓 Founded 2020👥 17 employees💰 Last funded Jul 2022
Biotechnology Research🌐 catamaranbio.com
Website LinkedIn
At Catamaran, our mission is to harness the power of our proprietary TAILWIND™ Platform to develop safe and effective, off-the-shelf, allogeneic immune cell therapies for the treatment of patients with cancer and immune disorders.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Catamaran Bio?
Catamaran Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Catamaran Bio last raise funding?
The most recent investment in Catamaran Bio recorded on gritt.io was in July 2022.
When was Catamaran Bio founded?
Catamaran Bio was founded in 2020.
What industry is Catamaran Bio in?
Catamaran Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Catamaran Bio based?
Catamaran Bio is headquartered in Boston, United States.